Brief: Dynavax Reports Fourth Quarter And Full Year 2022 Financial Results
Feb 23 (Reuters) - Dynavax Technologies Corp DVAX.O :
* DYNAVAX REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES FULL YEAR 2023 FINANCIAL GUIDANCE
* TOTAL REVENUE FOR Q4 OF 2022 WAS $184.5 MILLION, COMPARED
TO
$195.1 MILLION FOR Q4 OF 2021
* QTRLY EPS $0.45
* Q4 EARNINGS PER SHARE VIEW $0.43, REVENUE VIEW $179.6
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nPn3B2M2ba
Further company coverage: DVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality